Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index climbed nearly 4 percent in March driven by rising stock prices for Natera, Veracyte, and Fluidigm.

Overall, 22 of the 30 stocks that comprise the index saw increases. The 4 percent gain also beat the broader markets last month with the Dow Jones Industrial average essentially flat month over month, while the Nasdaq Composite grew almost 3 percent, and the Nasdaq Biotech was down about 1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.